Shattuck Labs (STTK) Revenue & Revenue Breakdown
Shattuck Labs Revenue Highlights
Latest Revenue (Y)
$1.66M
Latest Revenue (Q)
$1.61M
Shattuck Labs Revenue by Period
Shattuck Labs Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $1.66M | 154.14% |
| 2022-12-31 | $652.00K | -97.83% |
| 2021-12-31 | $30.02M | 202.16% |
| 2020-12-31 | $9.93M | 0.48% |
| 2019-12-31 | $9.89M | -55.94% |
| 2018-12-31 | $22.44M | - |
Shattuck Labs generated $1.66M in revenue during NA 2023, up 154.14% compared to the previous quarter, and up 7.38% compared to the same period a year ago.
Shattuck Labs Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $1.61M | 44.30% |
| 2024-03-31 | $1.11M | 56.16% |
| 2023-12-31 | $714.00K | 4.08% |
| 2023-09-30 | $686.00K | 243.00% |
| 2023-06-30 | $200.00K | 250.88% |
| 2023-03-31 | $57.00K | -85.38% |
| 2022-12-31 | $390.00K | 83.96% |
| 2022-09-30 | $212.00K | 324.00% |
| 2022-06-30 | $50.00K | 100.00% |
| 2022-03-31 | - | -100.00% |
| 2021-12-31 | $30.08M | 1483.05% |
| 2021-09-30 | $1.90M | -144.91% |
| 2021-06-30 | $-4.23M | -286.39% |
| 2021-03-31 | $2.27M | 69.15% |
| 2020-12-31 | $1.34M | -44.89% |
| 2020-09-30 | $2.44M | -23.45% |
| 2020-06-30 | $3.18M | 6.89% |
| 2020-03-31 | $2.98M | 5.49% |
| 2019-12-31 | $2.82M | 58.13% |
| 2019-09-30 | $1.78M | - |
Shattuck Labs generated $1.61M in revenue during Q2 2024, up 44.30% compared to the previous quarter, and up 2822.81% compared to the same period a year ago.
Shattuck Labs Revenue Breakdown
Shattuck Labs Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 |
|---|---|---|
| License | $1.50M | $800.00K |
Shattuck Labs's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: License (100.00%).
Shattuck Labs Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| KYMR | Kymera Therapeutics | $78.59M | $10.29M |
| NRIX | Nurix Therapeutics | $76.99M | $12.09M |
| FHTX | Foghorn Therapeutics | $34.16M | $6.89M |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| IPSC | Century Therapeutics | $2.23M | $771.00K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| CCCC | C4 Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| PMVP | PMV Pharmaceuticals | - | - |
| PRLD | Prelude Therapeutics | - | - |
| PRDS | Pardes Biosciences | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| CSBR | Champions Oncology | - | $12.02M |
STTK Revenue FAQ
What is Shattuck Labs’s yearly revenue?
Shattuck Labs's yearly revenue for 2023 was $1.66M, representing an increase of 154.14% compared to 2022. The company's yearly revenue for 2022 was $652K, representing a decrease of -97.83% compared to 2021. STTK's yearly revenue for 2021 was $30.02M, representing an increase of 202.16% compared to 2020.
What is Shattuck Labs’s quarterly revenue?
Shattuck Labs's quarterly revenue for Q2 2024 was $1.61M, a 44.30% increase from the previous quarter (Q1 2024), and a 704.50% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $1.12M, a 56.16% increase from the previous quarter (Q4 2023), and a 1856.14% increase year-over-year (Q1 2023). STTK's quarterly revenue for Q4 2023 was $714K, a 4.08% increase from the previous quarter (Q3 2023), and a 83.08% increase year-over-year (Q4 2022).
What is Shattuck Labs’s revenue growth rate?
Shattuck Labs's revenue growth rate for the last 3 years (2021-2023) was -94.48%, and for the last 5 years (2019-2023) was -83.24%.